These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 18952910

  • 1. ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.
    Zhu T, Awni WM, Hosmane B, Kelly MT, Sleep DJ, Stolzenbach JC, Wan K, Chira TO, Pradhan RS.
    J Clin Pharmacol; 2009 Jan; 49(1):63-71. PubMed ID: 18952910
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects.
    Gustavson LE, Schweitzer SM, Burt DA, Achari R, Rieser MJ, Edeki T, Chira T, Yannicelli HD, Kelly MT.
    Clin Ther; 2006 Mar; 28(3):373-87. PubMed ID: 16750452
    [Abstract] [Full Text] [Related]

  • 3. The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
    Schneck DW, Birmingham BK, Zalikowski JA, Mitchell PD, Wang Y, Martin PD, Lasseter KC, Brown CD, Windass AS, Raza A.
    Clin Pharmacol Ther; 2004 May; 75(5):455-63. PubMed ID: 15116058
    [Abstract] [Full Text] [Related]

  • 4. Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans.
    Bergman AJ, Murphy G, Burke J, Zhao JJ, Valesky R, Liu L, Lasseter KC, He W, Prueksaritanont T, Qiu Y, Hartford A, Vega JM, Paolini JF.
    J Clin Pharmacol; 2004 Sep; 44(9):1054-62. PubMed ID: 15317833
    [Abstract] [Full Text] [Related]

  • 5. Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia.
    Yang LP, Keating GM.
    Am J Cardiovasc Drugs; 2009 Sep; 9(6):401-9. PubMed ID: 19929038
    [Abstract] [Full Text] [Related]

  • 6. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.
    Simonson SG, Raza A, Martin PD, Mitchell PD, Jarcho JA, Brown CD, Windass AS, Schneck DW.
    Clin Pharmacol Ther; 2004 Aug; 76(2):167-77. PubMed ID: 15289793
    [Abstract] [Full Text] [Related]

  • 7. An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers.
    Martin PD, Dane AL, Schneck DW, Warwick MJ.
    Clin Ther; 2003 Feb; 25(2):459-71. PubMed ID: 12749507
    [Abstract] [Full Text] [Related]

  • 8. Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin.
    Busti AJ, Bain AM, Hall RG, Bedimo RG, Leff RD, Meek C, Mehvar R.
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):605-10. PubMed ID: 18520949
    [Abstract] [Full Text] [Related]

  • 9. Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.
    Yu CY, Campbell SE, Zhu B, Knadler MP, Small DS, Sponseller CA, Hunt TL, Morgan RE.
    Curr Med Res Opin; 2012 Feb; 28(2):187-94. PubMed ID: 22149769
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study.
    Mohiuddin SM, Pepine CJ, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC.
    Am Heart J; 2009 Jan; 157(1):195-203. PubMed ID: 19081418
    [Abstract] [Full Text] [Related]

  • 11. Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.
    Simonson SG, Martin PD, Mitchell PD, Lasseter K, Gibson G, Schneck DW.
    J Clin Pharmacol; 2005 Aug; 45(8):927-34. PubMed ID: 16027403
    [Abstract] [Full Text] [Related]

  • 12. Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults.
    Gosai P, Liu J, Doyle RT, Johnson J, Carter R, Sica D, McKenney JM.
    Expert Opin Pharmacother; 2008 Dec; 9(17):2947-53. PubMed ID: 19006471
    [Abstract] [Full Text] [Related]

  • 13. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.
    Martin PD, Warwick MJ, Dane AL, Brindley C, Short T.
    Clin Ther; 2003 Oct; 25(10):2553-63. PubMed ID: 14667956
    [Abstract] [Full Text] [Related]

  • 14. Steady-state pharmacokinetic interactions of darunavir/ritonavir with lipid-lowering agent rosuvastatin.
    Samineni D, Desai PB, Sallans L, Fichtenbaum CJ.
    J Clin Pharmacol; 2012 Jun; 52(6):922-31. PubMed ID: 21712498
    [Abstract] [Full Text] [Related]

  • 15. Effect of a single gemfibrozil dose on the pharmacokinetics of rosuvastatin in bile and plasma in healthy volunteers.
    Bergman E, Matsson EM, Hedeland M, Bondesson U, Knutson L, Lennernäs H.
    J Clin Pharmacol; 2010 Sep; 50(9):1039-49. PubMed ID: 20150523
    [Abstract] [Full Text] [Related]

  • 16. Myopathy caused by a combination rosuvastatin and fenofibrate.
    Dedhia V, Munsi SC.
    J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
    [No Abstract] [Full Text] [Related]

  • 17. Hepatic nuclear factor 1alpha inhibitor ursodeoxycholic acid influences pharmacokinetics of the organic anion transporting polypeptide 1B1 substrate rosuvastatin and bilirubin.
    He YJ, Zhang W, Tu JH, Kirchheiner J, Chen Y, Guo D, Li Q, Li ZY, Chen H, Hu DL, Wang D, Zhou HH.
    Drug Metab Dispos; 2008 Aug; 36(8):1453-6. PubMed ID: 18443034
    [Abstract] [Full Text] [Related]

  • 18. Acute renal failure with the combined use of rosuvastatin and fenofibrate.
    Buyukhatipoglu H, Sezen Y, Guntekin U, Kirhan I, Dag OF.
    Ren Fail; 2010 Jun; 32(5):633-5. PubMed ID: 20486848
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
    Cao YJ, Smith PF, Wire MB, Lou Y, Lancaster CT, Causon RC, Bigelow GE, Martinez E, Fuchs EJ, Radebaugh C, McCabe S, Hendrix CW.
    Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.